Skip to content
Aperlena
Free alerts

Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) verified 4 hours ago Contract notice

Request for Quotation No. 08-10-2026 AT

Original REQUEST FOR QUOTATION No. 08 10 2026 AT

Open Poland Małopolskie Research & development

Buyer RYVU THERAPEUTICS S.A.

7 days left

Key facts

Closes
23:59 (UTC+2)
  1. Published
  2. Today
  3. Deadline open for 8 days
  4. Awarded pending

Bidding window

7 days from publication to deadline

Shorter than usual

Notices of this kind (Poland, below the EU threshold) give a median of 12 days, half of them between 8 and 15 days, based on 92,785 notices of the last two years. Fewer days than three in four comparable notices. Check the documents early and ask questions before the clarification deadline.

This buyer usually gives 7 days (median of its last 20 calls for tender).

View the official notice Watch this tender
Add to calendar

If the deadline moves or the notice is corrected, we email you. Log in

Summary

Machine-generated summary

Ryvu is seeking a supplier to deliver a complete service consisting of a 2D cell viability assay based on quantitative ATP measurement with luminescence readout, performed on an individually selected panel of cancer cell lines, including drug-resistant variants generated through in vitro resistance induction and genetic editing, for payload/ADC compounds supplied by Ryvu. The scope includes a 5-day incubation, a 10-point concentration-response curve, EC50 determination and a T0 measurement for each cell line, with all testing performed in triplicate. The service will be carried out in Krakow, Poland, under laboratory research services (CPV 73111000-3).

Key points

Place of performance
Kraków (małopolskie)
Reference
2026-112-294314
Część 1: 1 Celem postępowania jest wybór dostawcy zdolnego do świadczenia kompleksowej usługi obejmującej wykonanie testu żywotności komórek metodą 2D opartą na ilościowym oznaczaniu ATP z odczytem luminescencyjnym, na indywidualnie dobranym panelu linii komórek nowotworowych (w tym wariantów opornych na leki, uzyskanych metodami indukowania oporności in vitro oraz edycji genetycznej), dla związków typu payload/ADC dostarczonych przez Ryvu. Zakres usługi obejmuje 5-dniową inkubację, 10-punktową krzywą zależności odpowiedzi od stężenia, wyznaczenie wartości EC₅₀ oraz pomiar T0 dla każdej linii komórkowej, przy czym wszystkie badania mają być wykonywane w trzech powtórzeniach (triplikatach). Pełny opis przedmiotu zamówienia znajduje się w załączonym zapytaniu ofertowym w wersji PDF. The objective is to select a vendor capable of providing a consolidated service that includes a 2D luminescence-based ATP-quantification cell viability assay performed on a custom-selected panel of cancer cell lines (including drug-resistant variants generated by in vitro drug-induced resistance and genetic editing methods) for payload/ADC compounds provided by Ryvu, incorporating a 5-day incubation, a 10-point concentration-response curve, EC₅₀ determination, and T0 measurement for each cell line, with all testing conducted in triplicate. A full description of the subject of the contract is provided in the attached request for quotation in PDF version. Źródło: Ministerstwo Funduszy i Polityki Regionalnej, Baza Konkurencyjności Funduszy Europejskich; pobrano 2026-10-08; dane przetworzone.
Original text
Numer ogłoszenia: 2026-112-294314 Część 1: 1 Celem postępowania jest wybór dostawcy zdolnego do świadczenia kompleksowej usługi obejmującej wykonanie testu żywotności komórek metodą 2D opartą na ilościowym oznaczaniu ATP z odczytem luminescencyjnym, na indywidualnie dobranym panelu linii komórek nowotworowych (w tym wariantów opornych na leki, uzyskanych metodami indukowania oporności in vitro oraz edycji genetycznej), dla związków typu payload/ADC dostarczonych przez Ryvu. Zakres usługi obejmuje 5-dniową inkubację, 10-punktową krzywą zależności odpowiedzi od stężenia, wyznaczenie wartości EC₅₀ oraz pomiar T0 dla każdej linii komórkowej, przy czym wszystkie badania mają być wykonywane w trzech powtórzeniach (triplikatach). Pełny opis przedmiotu zamówienia znajduje się w załączonym zapytaniu ofertowym w wersji PDF. The objective is to select a vendor capable of providing a consolidated service that includes a 2D luminescence-based ATP-quantification cell viability assay performed on a custom-selected panel of cancer cell lines (including drug-resistant variants generated by in vitro drug-induced resistance and genetic editing methods) for payload/ADC compounds provided by Ryvu, incorporating a 5-day incubation, a 10-point concentration-response curve, EC₅₀ determination, and T0 measurement for each cell line, with all testing conducted in triplicate. A full description of the subject of the contract is provided in the attached request for quotation in PDF version. CPV: 73111000-3 Laboratoryjne usługi badawcze Miejsce realizacji: Kraków (małopolskie) Źródło: Ministerstwo Funduszy i Polityki Regionalnej, Baza Konkurencyjności Funduszy Europejskich; pobrano 2026-10-08; dane przetworzone.

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. Your call:

    Do we meet every eligibility criterion?

    The register holds nothing on this. The official documents will.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Research & development.

  4. Check this first:

    Is the deadline realistic for a proper offer?

    7 days left, 5 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    In this country this kind of contract is usually awarded for between €24,672 and €213,195.

  6. Your call:

    Do we know this buyer?

    The buyer has 21 notices in the register and no pattern of winners yet.

Can I bid?

Official source

Source: Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej)

Always verify details on the official notice.

Report an error in this notice

Last verified against Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) 4 hours ago

Documents on Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) (Polish)

View the official notice

What this market pays

The buyer has too few awards of its own in this sector, so this is the range of the last 153 awards for Research & development in Poland.

Median award
€84,042
Middle half of past awards
€24,672 to €213,195

Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

The buyer

Full buyer profile

RYVU THERAPEUTICS S.A.

Poland

notices in the register
21

Who wins its contracts

of its calls state an estimated value
0%

This buyer has no award history in this sector yet. Usual winners, Research & development - Poland

Company Wins Total awarded Last win
IBC Advisory S.A. 8 €464,647 Jul 2026
EVALU Sp. z o.o. 5 €87,037 Aug 2026
ASM Research Solutions Strategy sp. z o.o. 5 €54,872 Mar 2026
EU-Consult Sp. z o.o. 4 €198,092 Jul 2026
STREFA PRZYRODY Kamil Martyniak 4 €38,696 Jun 2026

Based on 275 awards with a linked company profile over the last 2 years.

4 open tenders right now

Market context

Baza Konkurencyjności Funduszy Europejskich (Ministerstwo Funduszy i Polityki Regionalnej) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Research & development
660
median open notice
€300,000

Who wins in this market

Many suppliers

Poland · Research & development

different companies won awards here
214
of the awards went to the three most frequent winners
7%
buyers awarded contracts here
132

Based on 275 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
2.3
of those lots received a single tender
33%
of the awards went to companies based in another country
6%
of the tenders came from another country
6%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

44 new notices in Research & development in Poland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

7 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language